Introduction
Different clonal lineages have been associated with extraintestinal pathogenic Escherichia coli (ExPEC) infections in human patients. 1 In 2008, ST131 E. coli was discovered, a new clonal linage present in E. coli of both human and animal origin.
2 ST131 E. coli is now the predominant lineage among human ExPEC infections worldwide. 2 From its global dissemination and predominance, it is suggested that ST131 E. coli is a cause of the steady increase in resistance to antimicrobial agents. 3 From 2014 to 2016, ST131 was the most frequently detected ST among ESBL and plasmid-mediated AmpC (pAmpC)-producing E. coli isolates from human bloodstream infections in Denmark, whereas the pAmpC enzyme CMY-2 was only sporadically detected. 4 The opposite was seen for E. coli isolates of animal origin, where CMY-2 was often detected, particularly among broilers, but few E. coli isolates of animal origin belonged to ST131. 4 To the best of our knowledge, the first ST131 CMY-2-producing E. coli isolate causing bloodstream infection was detected in a Danish patient in 2016.
This study compares the genome of the ST131 CMY-2-producing E. coli isolate from a Danish patient with genomes of other ST131 CMY-2-producing E. coli isolates of both human and animal origin. Additionally, the CMY-2-carrying plasmid was fully sequenced and annotated. The plasmid data were used for further analysis of plasmid content of other ST131 CMY-2-producing E. coli isolates.
Materials and methods

Isolate and genome collection
In 2016, an ST131 CMY-2-producing E. coli isolate (ESBL20160056) was obtained from an elderly Danish patient with bloodstream infection and submitted to the Statens Serum Institut (Copenhagen, Denmark), as part of the Danish surveillance programme DANMAP. 4 During 2014-16, six ST131 CMY-2-producing E. coli isolates were collected in Denmark from broiler meat samples imported from France, the Netherlands and Germany, as part of the DANMAP programme. [4] [5] [6] Genomic DNA extraction, fragment libraries and sequencing were performed as previously described. 7 For an extended comparison, all ST131 E. coli genomes from Enterobase were searched for the presence of bla CMY-2 (search performed 16 June 2017). Fifteen genomes with 100% match to bla CMY-2 and available metadata on isolation source, country and year were included in the study (Table S1 , available as Supplementary data at JAC Online). Network collaborators of the European Union Reference Laboratory for Antimicrobial Resistance were invited to participate with sequence data of ST131 CMY-2-producing E. coli; one isolate from Luxembourg and one from Belgium, both of broiler origin, were reported and included in the study.
The raw reads of all 24 isolates were assembled into draft genomes using the SPAdes assembler v3.10.1. 8 
Genotypic characterization
Draft genomes were genotyped by submission to the Bacterial Analysis Platform 9 at the Center for Genomic Epidemiology (CGE) (https://cge.cbs. dtu.dk/services/cge/) and analysed using the CGE tools described below (analysis performed 28 May 2018). ResFinder v2.1 was used for the identification of bla CMY-2 resistance genes, using a threshold of 100% identity. 9 The E. coli genomes were typed with the Achtman scheme by using MLST v1.6 9 and fimH subtyped using FimTyper v1.0. 10 
Plasmid sequencing and analysis
The bla CMY-2 -encoding plasmid from ESBL20160056 was fully sequenced with an R9.4 flow cell in a MinION Mk1B (Oxford Nanopore Technologies). Raw reads were base-called with ONT's Albacore v2. Illumina reads from the isolate were trimmed with Trimmomatic v0.36, 12 leaving 2%150 megabases and used for the hybrid assembly using Unicycler (v0.4.0). 13 The plasmid sequence (pESBL20160056-CMY-2) was manually corrected using reference mapping of Illumina and MinION reads in CLC Genomic Workbench v.11 (Qiagen, Aarhus, Denmark) and it has been deposited under GenBank accession no. MH472638.
Plasmid replicons and plasmid MLST (pMLST) were identified for draft genomes for all 24 isolates, using PlasmidFinder 1.4 and pMLST 1.4, respectively. 9 BLAST analysis of draft genomes against the closed plasmid pESBL20160056-CMY-2 was performed using the GView Server (https://ser ver.gview.ca/).
Genomic epidemiology
SNP variants were called by aligning WGS data against the chromosome of E. coli strain JJ1886 (GenBank accession no. NC_022648.1) or the closed plasmid pESBL20160056-CMY-2, as previously described.
14 Gubbins was used to remove the recombination. 15 The phylogenetic dendrogram was depicted using iToL (http://itol.embl.de/). 16 
Results and discussion
From 2014 to 2016, the Danish surveillance programme DANMAP reported 436 (52%) ST131 third-generation cephalosporin-resistant (3GC-R) E. coli isolates causing human bloodstream infections. Only one ST131 CMY-2-producing E. coli isolate was reported among these (ESBL20160056). The isolate was from an elderly patient. To our knowledge, the patient had not been travelling prior to hospitalization. From 2014 to 2016, seven ST131 E. coli isolates were observed among 319 E. coli isolates of animal or meat origin. 4 Six of the seven ST131 E. coli isolates were CMY-2 producers. From a search in the Enterobase database, 15 ST131 E. coli genomes with bla CMY-2 were detected. The 24 ST131 CMY-2-producing E. coli isolates included in the current study were collected between 2009 and 2016 from 11 different countries ( Figure 1 and Table S1 ). Of the 24 E. coli isolates, 13 were of human origin, 3 were collected from broilers and the remaining 8 collected from broiler meat samples.
The 24 ST131 CMY-2-producing isolates belonged to six different fimH subtypes: fimH22 (14 of 24), fimH30 (4 of 24), fimH41 (3 of 24), fimH298 (1 of 24), fimH683 (1 of 24) and fimH1198 (1 of 24). In the SNP-based phylogeny (Figure 1) , the genomes clustered according to their fimH variant, with the single nucleotide derivative of fimH30 (fimH1198) located within the fimH30 clade. The E. coli isolate from the Danish patient was subtyped as a fimH22 isolate and clustered together with the 13 other fimH22 isolates in a distinct clade with 0-275 SNPs between the genomes and 405 SNPs between the clade to the closest genome outside the clade. Of the 14 ST131 E. coli isolates clustering in the fimH22 clade, six were isolated from humans collected in Denmark, Spain, Cambodia and the USA, six were isolated from broiler meat samples collected in France, the Netherlands and Germany, and two were isolated from broilers collected in Belgium and Luxembourg (Figure 1 ). The four closest ST131 CMY-2-producing E. coli isolates in the fimH22 clade had 22-27 SNPs compared with the ST131 CMY-2-producing E. coli isolate from the Danish patient. Three of these isolates were obtained from broiler meat imported to Denmark from France, Germany and the Netherlands, while the fourth was a human isolate originating from Cambodia.
Liu et al. 17 have recently reported ST131 fimH22 E. coli to be a foodborne uropathogen E. coli. Unfortunately, we did not have information for the Danish patient about consumption of broiler meat nor animal contact prior to the infection.
The plasmid encoding bla CMY-2 from the E. coli isolate from the Danish patient was sequenced and annotated. The bla CMY-2 gene was detected on a 101 575 bp plasmid with an IncI1 replicon and belonged to ST12 using the pMLST scheme. In this study, 10 of the 14 ST131 E. coli isolates belonging to the fimH22 clade had an IncI1 ST12 plasmid (Figure 1 ). An SNP comparison of the nine other IncI1 ST12 plasmids to the closed plasmid pESBL20160056-CMY-2 from the Danish patient showed 0-47 SNPs (data not shown). Four of the plasmids obtained from the E. coli isolates from imported broiler meat samples from DANMAP showed 0-1 SNP differences to pESBL20160056-CMY-2 obtained from the E. coli from the Danish patient. Furthermore, a BLAST comparison indicated a highly conserved plasmid backbone in all 10 IncI1 ST12 plasmids (Figure 2 ). Additionally, a postsegregational killing system (toxin/antitoxin system) for plasmid maintenance was located on the IncI1 ST12 plasmid together with the bla CMY-2 gene.
Hansen et al. 18 detected an ST131 E. coli isolate with bla CMY-2 on a 100 kb IncI1 ST12 plasmid from a Danish broiler parent flock from 2011; however, to the best of our knowledge, an ST131 CMY-2-producing E. coli isolate has not been reported from a Danish Highly similar ST131 E. coli of human and broiler origin JAC patient before. Further, Hansen et al. 18 detected 100 kb IncI1/ST12 plasmids with bla CMY-2 in 21 E. coli isolates belonging to 20 non-ST131 STs, obtained from humans, dogs and broilers in Denmark. bla CMY-2 /IncI1/ST12 plasmids have also been detected from the E. coli isolates obtained from poultry in Columbia. 19 Combined, these data indicate a zoonotic reservoir for bla CMY-2 /IncI1/ST12 plasmids, which can be transferred to more pathogenic E. coli isolates, such as ST131 E. coli, which can cause infections in humans.
In conclusion, it seems plausible that the ST131 fimH22 CMY-2-producing E. coli from the Danish patient has a zoonotic origin, as three closely related isolates were found in meat products sold in Denmark prior to the time of infection and an isolate from a Danish broiler flock from 2011 detected by Hansen et al. 18 Arguably, the relatively small number of isolates in the ST131 fimH22 CMY-2 clade is not enough to give conclusive proof of this hypothesis, but it is striking that the three clustering meat samples originate from three different European countries. This could indicate that ST131 fimH22 CMY-2-producing E. coli isolates have a wider distribution among poultry than just a single farm or a single country. Further studies are needed to detect the transmission route of this clone; it is possible that this clone could be transferred from humans to poultry or alternatively there could be an unknown environmental source of H22.
